0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Nuclear Medicine Isotopes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-20D5817
Home | Market Reports | Business & Industrial| Energy & Utilities
Global Nuclear Medicine Isotopes Market Insights Forecast to 2028
BUY CHAPTERS

Nuclear Medicine Isotopes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-20D5817
Report
September 2024
Pages:157
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Medicine Isotopes - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Nuclear Medicine Isotopes - Market

Nuclear Medicine Isotopes - Market

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use. In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
The global market for Nuclear Medicine Isotopes was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Isotopes, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nuclear Medicine Isotopes by region & country, by Type, and by Application.
The Nuclear Medicine Isotopes market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Isotopes.
Market Segmentation

Scope of Nuclear Medicine Isotopes - Market Report

Report Metric Details
Report Name Nuclear Medicine Isotopes - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NRG, NTP Radioisotopes, JSC Isotope, ANSTO, IRE, Nordion, Curium Pharma, Cambridge Isotope Laboratories, Eckert & Ziegler Strahlen, Polatom, Center of Molecular Research, China National Nuclear Corporation, Urenco, LANL, Shanghai Engineering Research Center, IDB Holland, NHTC, Linde, ORNL, SI Science
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Nuclear Medicine Isotopes manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Nuclear Medicine Isotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Nuclear Medicine Isotopes in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Nuclear Medicine Isotopes - Market report?

Ans: The main players in the Nuclear Medicine Isotopes - Market are NRG, NTP Radioisotopes, JSC Isotope, ANSTO, IRE, Nordion, Curium Pharma, Cambridge Isotope Laboratories, Eckert & Ziegler Strahlen, Polatom, Center of Molecular Research, China National Nuclear Corporation, Urenco, LANL, Shanghai Engineering Research Center, IDB Holland, NHTC, Linde, ORNL, SI Science

What are the Application segmentation covered in the Nuclear Medicine Isotopes - Market report?

Ans: The Applications covered in the Nuclear Medicine Isotopes - Market report are Nuclear Therapy, Equipment Radioactive Source, Diagnosis

What are the Type segmentation covered in the Nuclear Medicine Isotopes - Market report?

Ans: The Types covered in the Nuclear Medicine Isotopes - Market report are Stable Isotopes, Radioisotopes

Recommended Reports

Nuclear Medicine Markets

Radioisotope & Therapy

Medical Devices & Equipment

1 Market Overview
1.1 Nuclear Medicine Isotopes Product Introduction
1.2 Global Nuclear Medicine Isotopes Market Size Forecast
1.3 Nuclear Medicine Isotopes Market Trends & Drivers
1.3.1 Nuclear Medicine Isotopes Industry Trends
1.3.2 Nuclear Medicine Isotopes Market Drivers & Opportunity
1.3.3 Nuclear Medicine Isotopes Market Challenges
1.3.4 Nuclear Medicine Isotopes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nuclear Medicine Isotopes Players Revenue Ranking (2023)
2.2 Global Nuclear Medicine Isotopes Revenue by Company (2019-2024)
2.3 Key Companies Nuclear Medicine Isotopes Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nuclear Medicine Isotopes Product Offered
2.5 Key Companies Time to Begin Mass Production of Nuclear Medicine Isotopes
2.6 Nuclear Medicine Isotopes Market Competitive Analysis
2.6.1 Nuclear Medicine Isotopes Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nuclear Medicine Isotopes Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Isotopes as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stable Isotopes
3.1.2 Radioisotopes
3.2 Global Nuclear Medicine Isotopes Sales Value by Type
3.2.1 Global Nuclear Medicine Isotopes Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nuclear Medicine Isotopes Sales Value, by Type (2019-2030)
3.2.3 Global Nuclear Medicine Isotopes Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Nuclear Therapy
4.1.2 Equipment Radioactive Source
4.1.3 Diagnosis
4.2 Global Nuclear Medicine Isotopes Sales Value by Application
4.2.1 Global Nuclear Medicine Isotopes Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nuclear Medicine Isotopes Sales Value, by Application (2019-2030)
4.2.3 Global Nuclear Medicine Isotopes Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nuclear Medicine Isotopes Sales Value by Region
5.1.1 Global Nuclear Medicine Isotopes Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nuclear Medicine Isotopes Sales Value by Region (2019-2024)
5.1.3 Global Nuclear Medicine Isotopes Sales Value by Region (2025-2030)
5.1.4 Global Nuclear Medicine Isotopes Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nuclear Medicine Isotopes Sales Value, 2019-2030
5.2.2 North America Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nuclear Medicine Isotopes Sales Value, 2019-2030
5.3.2 Europe Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nuclear Medicine Isotopes Sales Value, 2019-2030
5.4.2 Asia Pacific Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nuclear Medicine Isotopes Sales Value, 2019-2030
5.5.2 South America Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nuclear Medicine Isotopes Sales Value, 2019-2030
5.6.2 Middle East & Africa Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nuclear Medicine Isotopes Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nuclear Medicine Isotopes Sales Value
6.3 United States
6.3.1 United States Nuclear Medicine Isotopes Sales Value, 2019-2030
6.3.2 United States Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nuclear Medicine Isotopes Sales Value, 2019-2030
6.4.2 Europe Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nuclear Medicine Isotopes Sales Value, 2019-2030
6.5.2 China Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nuclear Medicine Isotopes Sales Value, 2019-2030
6.6.2 Japan Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nuclear Medicine Isotopes Sales Value, 2019-2030
6.7.2 South Korea Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nuclear Medicine Isotopes Sales Value, 2019-2030
6.8.2 Southeast Asia Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nuclear Medicine Isotopes Sales Value, 2019-2030
6.9.2 India Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 NRG
7.1.1 NRG Profile
7.1.2 NRG Main Business
7.1.3 NRG Nuclear Medicine Isotopes Products, Services and Solutions
7.1.4 NRG Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.1.5 NRG Recent Developments
7.2 NTP Radioisotopes
7.2.1 NTP Radioisotopes Profile
7.2.2 NTP Radioisotopes Main Business
7.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Products, Services and Solutions
7.2.4 NTP Radioisotopes Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.2.5 NTP Radioisotopes Recent Developments
7.3 JSC Isotope
7.3.1 JSC Isotope Profile
7.3.2 JSC Isotope Main Business
7.3.3 JSC Isotope Nuclear Medicine Isotopes Products, Services and Solutions
7.3.4 JSC Isotope Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.3.5 ANSTO Recent Developments
7.4 ANSTO
7.4.1 ANSTO Profile
7.4.2 ANSTO Main Business
7.4.3 ANSTO Nuclear Medicine Isotopes Products, Services and Solutions
7.4.4 ANSTO Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.4.5 ANSTO Recent Developments
7.5 IRE
7.5.1 IRE Profile
7.5.2 IRE Main Business
7.5.3 IRE Nuclear Medicine Isotopes Products, Services and Solutions
7.5.4 IRE Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.5.5 IRE Recent Developments
7.6 Nordion
7.6.1 Nordion Profile
7.6.2 Nordion Main Business
7.6.3 Nordion Nuclear Medicine Isotopes Products, Services and Solutions
7.6.4 Nordion Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.6.5 Nordion Recent Developments
7.7 Curium Pharma
7.7.1 Curium Pharma Profile
7.7.2 Curium Pharma Main Business
7.7.3 Curium Pharma Nuclear Medicine Isotopes Products, Services and Solutions
7.7.4 Curium Pharma Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.7.5 Curium Pharma Recent Developments
7.8 Cambridge Isotope Laboratories
7.8.1 Cambridge Isotope Laboratories Profile
7.8.2 Cambridge Isotope Laboratories Main Business
7.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Products, Services and Solutions
7.8.4 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.8.5 Cambridge Isotope Laboratories Recent Developments
7.9 Eckert & Ziegler Strahlen
7.9.1 Eckert & Ziegler Strahlen Profile
7.9.2 Eckert & Ziegler Strahlen Main Business
7.9.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Products, Services and Solutions
7.9.4 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.9.5 Eckert & Ziegler Strahlen Recent Developments
7.10 Polatom
7.10.1 Polatom Profile
7.10.2 Polatom Main Business
7.10.3 Polatom Nuclear Medicine Isotopes Products, Services and Solutions
7.10.4 Polatom Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.10.5 Polatom Recent Developments
7.11 Center of Molecular Research
7.11.1 Center of Molecular Research Profile
7.11.2 Center of Molecular Research Main Business
7.11.3 Center of Molecular Research Nuclear Medicine Isotopes Products, Services and Solutions
7.11.4 Center of Molecular Research Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.11.5 Center of Molecular Research Recent Developments
7.12 China National Nuclear Corporation
7.12.1 China National Nuclear Corporation Profile
7.12.2 China National Nuclear Corporation Main Business
7.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Products, Services and Solutions
7.12.4 China National Nuclear Corporation Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.12.5 China National Nuclear Corporation Recent Developments
7.13 Urenco
7.13.1 Urenco Profile
7.13.2 Urenco Main Business
7.13.3 Urenco Nuclear Medicine Isotopes Products, Services and Solutions
7.13.4 Urenco Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.13.5 Urenco Recent Developments
7.14 LANL
7.14.1 LANL Profile
7.14.2 LANL Main Business
7.14.3 LANL Nuclear Medicine Isotopes Products, Services and Solutions
7.14.4 LANL Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.14.5 LANL Recent Developments
7.15 Shanghai Engineering Research Center
7.15.1 Shanghai Engineering Research Center Profile
7.15.2 Shanghai Engineering Research Center Main Business
7.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Products, Services and Solutions
7.15.4 Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.15.5 Shanghai Engineering Research Center Recent Developments
7.16 IDB Holland
7.16.1 IDB Holland Profile
7.16.2 IDB Holland Main Business
7.16.3 IDB Holland Nuclear Medicine Isotopes Products, Services and Solutions
7.16.4 IDB Holland Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.16.5 IDB Holland Recent Developments
7.17 NHTC
7.17.1 NHTC Profile
7.17.2 NHTC Main Business
7.17.3 NHTC Nuclear Medicine Isotopes Products, Services and Solutions
7.17.4 NHTC Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.17.5 NHTC Recent Developments
7.18 Linde
7.18.1 Linde Profile
7.18.2 Linde Main Business
7.18.3 Linde Nuclear Medicine Isotopes Products, Services and Solutions
7.18.4 Linde Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.18.5 Linde Recent Developments
7.19 ORNL
7.19.1 ORNL Profile
7.19.2 ORNL Main Business
7.19.3 ORNL Nuclear Medicine Isotopes Products, Services and Solutions
7.19.4 ORNL Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.19.5 ORNL Recent Developments
7.20 SI Science
7.20.1 SI Science Profile
7.20.2 SI Science Main Business
7.20.3 SI Science Nuclear Medicine Isotopes Products, Services and Solutions
7.20.4 SI Science Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.20.5 SI Science Recent Developments
8 Industry Chain Analysis
8.1 Nuclear Medicine Isotopes Industrial Chain
8.2 Nuclear Medicine Isotopes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nuclear Medicine Isotopes Sales Model
8.5.2 Sales Channel
8.5.3 Nuclear Medicine Isotopes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Nuclear Medicine Isotopes Market Trends
    Table 2. Nuclear Medicine Isotopes Market Drivers & Opportunity
    Table 3. Nuclear Medicine Isotopes Market Challenges
    Table 4. Nuclear Medicine Isotopes Market Restraints
    Table 5. Global Nuclear Medicine Isotopes Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nuclear Medicine Isotopes Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Nuclear Medicine Isotopes Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Nuclear Medicine Isotopes Product Type
    Table 9. Key Companies Time to Begin Mass Production of Nuclear Medicine Isotopes
    Table 10. Global Nuclear Medicine Isotopes Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Isotopes as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Nuclear Medicine Isotopes Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Nuclear Medicine Isotopes Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Nuclear Medicine Isotopes Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Nuclear Medicine Isotopes Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Nuclear Medicine Isotopes Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Nuclear Medicine Isotopes Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Nuclear Medicine Isotopes Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Nuclear Medicine Isotopes Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Nuclear Medicine Isotopes Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Nuclear Medicine Isotopes Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Nuclear Medicine Isotopes Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Nuclear Medicine Isotopes Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Nuclear Medicine Isotopes Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Nuclear Medicine Isotopes Sales Value by Region (2019-2024) & (%)
    Table 27. Global Nuclear Medicine Isotopes Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Nuclear Medicine Isotopes Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Nuclear Medicine Isotopes Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Nuclear Medicine Isotopes Sales Value, (2025-2030) & (US$ Million)
    Table 31. NRG Basic Information List
    Table 32. NRG Description and Business Overview
    Table 33. NRG Nuclear Medicine Isotopes Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of NRG (2019-2024)
    Table 35. NRG Recent Developments
    Table 36. NTP Radioisotopes Basic Information List
    Table 37. NTP Radioisotopes Description and Business Overview
    Table 38. NTP Radioisotopes Nuclear Medicine Isotopes Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of NTP Radioisotopes (2019-2024)
    Table 40. NTP Radioisotopes Recent Developments
    Table 41. JSC Isotope Basic Information List
    Table 42. JSC Isotope Description and Business Overview
    Table 43. JSC Isotope Nuclear Medicine Isotopes Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of JSC Isotope (2019-2024)
    Table 45. JSC Isotope Recent Developments
    Table 46. ANSTO Basic Information List
    Table 47. ANSTO Description and Business Overview
    Table 48. ANSTO Nuclear Medicine Isotopes Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of ANSTO (2019-2024)
    Table 50. ANSTO Recent Developments
    Table 51. IRE Basic Information List
    Table 52. IRE Description and Business Overview
    Table 53. IRE Nuclear Medicine Isotopes Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of IRE (2019-2024)
    Table 55. IRE Recent Developments
    Table 56. Nordion Basic Information List
    Table 57. Nordion Description and Business Overview
    Table 58. Nordion Nuclear Medicine Isotopes Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Nordion (2019-2024)
    Table 60. Nordion Recent Developments
    Table 61. Curium Pharma Basic Information List
    Table 62. Curium Pharma Description and Business Overview
    Table 63. Curium Pharma Nuclear Medicine Isotopes Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Curium Pharma (2019-2024)
    Table 65. Curium Pharma Recent Developments
    Table 66. Cambridge Isotope Laboratories Basic Information List
    Table 67. Cambridge Isotope Laboratories Description and Business Overview
    Table 68. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Cambridge Isotope Laboratories (2019-2024)
    Table 70. Cambridge Isotope Laboratories Recent Developments
    Table 71. Eckert & Ziegler Strahlen Basic Information List
    Table 72. Eckert & Ziegler Strahlen Description and Business Overview
    Table 73. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Eckert & Ziegler Strahlen (2019-2024)
    Table 75. Eckert & Ziegler Strahlen Recent Developments
    Table 76. Polatom Basic Information List
    Table 77. Polatom Description and Business Overview
    Table 78. Polatom Nuclear Medicine Isotopes Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Polatom (2019-2024)
    Table 80. Polatom Recent Developments
    Table 81. Center of Molecular Research Basic Information List
    Table 82. Center of Molecular Research Description and Business Overview
    Table 83. Center of Molecular Research Nuclear Medicine Isotopes Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Center of Molecular Research (2019-2024)
    Table 85. Center of Molecular Research Recent Developments
    Table 86. China National Nuclear Corporation Basic Information List
    Table 87. China National Nuclear Corporation Description and Business Overview
    Table 88. China National Nuclear Corporation Nuclear Medicine Isotopes Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of China National Nuclear Corporation (2019-2024)
    Table 90. China National Nuclear Corporation Recent Developments
    Table 91. Urenco Basic Information List
    Table 92. Urenco Description and Business Overview
    Table 93. Urenco Nuclear Medicine Isotopes Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Urenco (2019-2024)
    Table 95. Urenco Recent Developments
    Table 96. LANL Basic Information List
    Table 97. LANL Description and Business Overview
    Table 98. LANL Nuclear Medicine Isotopes Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of LANL (2019-2024)
    Table 100. LANL Recent Developments
    Table 101. Shanghai Engineering Research Center Basic Information List
    Table 102. Shanghai Engineering Research Center Description and Business Overview
    Table 103. Shanghai Engineering Research Center Nuclear Medicine Isotopes Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Shanghai Engineering Research Center (2019-2024)
    Table 105. Shanghai Engineering Research Center Recent Developments
    Table 106. IDB Holland Basic Information List
    Table 107. IDB Holland Description and Business Overview
    Table 108. IDB Holland Nuclear Medicine Isotopes Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of IDB Holland (2019-2024)
    Table 110. IDB Holland Recent Developments
    Table 111. NHTC Basic Information List
    Table 112. NHTC Description and Business Overview
    Table 113. NHTC Nuclear Medicine Isotopes Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of NHTC (2019-2024)
    Table 115. NHTC Recent Developments
    Table 116. Linde Basic Information List
    Table 117. Linde Description and Business Overview
    Table 118. Linde Nuclear Medicine Isotopes Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of Linde (2019-2024)
    Table 120. Linde Recent Developments
    Table 121. ORNL Basic Information List
    Table 122. ORNL Description and Business Overview
    Table 123. ORNL Nuclear Medicine Isotopes Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of ORNL (2019-2024)
    Table 125. ORNL Recent Developments
    Table 126. SI Science Basic Information List
    Table 127. SI Science Description and Business Overview
    Table 128. SI Science Nuclear Medicine Isotopes Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Nuclear Medicine Isotopes Business of SI Science (2019-2024)
    Table 130. SI Science Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Nuclear Medicine Isotopes Downstream Customers
    Table 134. Nuclear Medicine Isotopes Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
    Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Nuclear Medicine Isotopes Product Picture
    Figure 2. Global Nuclear Medicine Isotopes Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nuclear Medicine Isotopes Sales Value (2019-2030) & (US$ Million)
    Figure 4. Nuclear Medicine Isotopes Report Years Considered
    Figure 5. Global Nuclear Medicine Isotopes Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine Isotopes Revenue in 2023
    Figure 7. Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Stable Isotopes Picture
    Figure 9. Radioisotopes Picture
    Figure 10. Global Nuclear Medicine Isotopes Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Nuclear Medicine Isotopes Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Nuclear Therapy
    Figure 13. Product Picture of Equipment Radioactive Source
    Figure 14. Product Picture of Diagnosis
    Figure 15. Global Nuclear Medicine Isotopes Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Nuclear Medicine Isotopes Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Nuclear Medicine Isotopes Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Nuclear Medicine Isotopes Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Nuclear Medicine Isotopes Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Nuclear Medicine Isotopes Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Nuclear Medicine Isotopes Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Nuclear Medicine Isotopes Sales Value (%), (2019-2030)
    Figure 28. United States Nuclear Medicine Isotopes Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Nuclear Medicine Isotopes Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Nuclear Medicine Isotopes Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Nuclear Medicine Isotopes Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Nuclear Medicine Isotopes Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Nuclear Medicine Isotopes Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Nuclear Medicine Isotopes Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Nuclear Medicine Isotopes Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Nuclear Medicine Isotopes Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Nuclear Medicine Isotopes Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Nuclear Medicine Isotopes Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Nuclear Medicine Isotopes Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Nuclear Medicine Isotopes Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Nuclear Medicine Isotopes Sales Value by Application (%), 2023 VS 2030
    Figure 49. Nuclear Medicine Isotopes Industrial Chain
    Figure 50. Nuclear Medicine Isotopes Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Advanced Fuel Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14S7936
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Maximum Power Point Tracking Charge Controllers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22D7379
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global DIN Rail Buffer Modules Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23Q8548
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Smart Tracker Battery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y8082
Tue Sep 16 00:00:00 UTC 2025

Add to Cart